OriGen Biomedical Company Profile
Background
Overview
OriGen Biomedical, Inc. is a privately held medical device manufacturer specializing in cryopreservation and cell culture products. Founded in 1997 and headquartered in Austin, Texas, the company focuses on developing products to support the treatment of cancer, genetic conditions, and other life-threatening diseases. OriGen Biomedical is committed to patient-centric design and exceptional customer service.
Mission and Vision
The company's mission is to provide innovative medical products that improve patient health. Its vision is to be the supplier of choice for single-use disposables within cell and gene therapy, supporting transformational therapies worldwide.
Industry Significance
OriGen Biomedical plays a crucial role in the medical device industry by offering specialized products that enhance the efficacy and safety of cell and gene therapies, thereby contributing to advancements in regenerative medicine.
Key Strategic Focus
Core Objectives
OriGen Biomedical aims to develop high-quality, user-friendly products that support the treatment of critical health conditions, ensuring improved patient outcomes.
Areas of Specialization
The company specializes in cryopreservation and cell culture products, including single-use disposables, cell culture bags, cryobags, and bioprocessing solutions.
Key Technologies Utilized
OriGen Biomedical employs advanced materials and manufacturing techniques to produce its products, ensuring compatibility with various cell and gene therapy applications.
Primary Markets Targeted
The company's products are primarily targeted at healthcare providers, research institutions, and biotechnology companies involved in cell and gene therapies, regenerative medicine, and bioprocessing.
Financials and Funding
Funding History
OriGen Biomedical is a privately held company and has not publicly disclosed detailed funding history or financials.
Revenue
In 2020, the company reported an estimated annual revenue of $27.8 million.
Utilization of Capital
While specific details on the utilization of capital are not publicly available, it is likely that funds are allocated towards research and development, manufacturing capabilities, and expanding market reach.
Pipeline Development
Key Pipeline Candidates
OriGen Biomedical's product pipeline includes cryopreservation and cell culture products designed to support cell and gene therapies. Specific details on pipeline candidates and development stages are not publicly disclosed.
Target Conditions
The company's products are intended for use in the treatment of cancer, genetic conditions, and other life-threatening diseases.
Anticipated Milestones
OriGen Biomedical has achieved several milestones, including the FDA clearance of the CryoStore Multi-Chamber Freezing Bag in 2019 and the CE mark for the CryoStore FLEX Freezing Bag in 2022.
Technological Platform and Innovation
Proprietary Technologies
OriGen Biomedical has developed proprietary products such as the CryoStore and CryoStore FLEX Freezing Bags, designed for the storage and transport of biological materials at ultra-low temperatures.
Significant Scientific Methods
The company employs advanced materials and manufacturing techniques to ensure the compatibility and safety of its products for various cell and gene therapy applications.
Leadership Team
Beth San Segundo, MBA
- Position: President & CEO
- Professional Background: Joined OriGen Biomedical in 1998, serving in various roles including Director of Marketing and Sales. Appointed President & CEO in June 2019. Holds a Bachelor of Arts in Biology and an MBA.
Nathan Thompson
- Position: Director of Engineering
- Professional Background: Joined OriGen Biomedical in 2009 as a Product Engineer. Oversees engineering department operations, including process validation and design development. Holds a Bachelor of Science in Biomedical Engineering.
Amanda Cooper
- Position: Director of Human Resources
- Professional Background: Joined OriGen Biomedical in 2019 as Human Resources Manager. Oversees recruiting and compensation programs. Holds a Bachelor of Science in General Studies and a Minor in Spanish.
Greg Sansom
- Position: Chief Financial Officer
- Professional Background: Joined OriGen Biomedical in 2009. Manages finance and accounting functions, including payroll and benefits administration. Holds a Bachelor of Business Administration in Accounting and a Master of Science in Accounting.
Tonia Wilson, MBA
- Position: Director of Global Business Development
- Professional Background: Joined OriGen Biomedical in 2010 as a Customer Service Representative. Oversees Customer Service, Sales, and Logistics departments. Holds a Bachelor of Science in Healthcare Administration and an MBA.
Adam McPherson, MBA
- Position: Director of Marketing
- Professional Background: Joined OriGen Biomedical in 2022. Leads marketing strategies and initiatives. Holds a Bachelor of Business Administration in Organizational Management and an MBA with a concentration in Marketing.
Deborah Rutt
- Position: Director of Operations
- Professional Background: Joined OriGen Biomedical in 2019. Oversees manufacturing processes, including teams in manufacturing, purchasing, and global inventory management. Holds a Higher National Diploma in Applied Food Science.
Sam Saleh
- Position: Director of Quality Assurance & Regulatory Affairs
